Bliss GVS Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

280.31

286.13

328.90

307.46

232.84

Operating profit

53.36

45.78

50.50

58.70

44.98

Interest

2.49

3.88

2.49

1.84

1.55

Gross profit

68.01

74.77

66.76

70.74

53.56

EPS (Rs)

3.96

4.82

4.46

4.48

3.48

Other income

17.14

32.86

18.75

13.88

10.13

Stock adjustment

-12.49

6.88

9.84

-18.74

-3.12

Raw material

146.73

148.02

170.34

180.49

94.95

Power and fuel

-

-

-

-

-

Employee expenses

40.74

35.34

33.26

31.79

27.77

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

51.97

50.10

64.95

55.22

68.27

Provisions made

-

-

-

-

-

Depreciation

11.04

7.41

6.92

6.93

6.88

Taxation

15.58

17.27

16.31

17.43

10.79

Net profit / loss

41.39

50.09

46.28

46.39

35.88

Extra ordinary item

-

-

2.75

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.44

10.39

10.37

10.35

10.31

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

19.04

16.00

15.36

19.09

19.32

GPM (%)

22.87

23.44

19.20

22.01

22.04

NPM (%)

13.91

15.70

13.31

14.43

14.77